Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-12-04

Clinical Trial Update: Comparison Efficacy in Patients With Asthma Using Foster MDI and Relvar Medications [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update comparing efficacy of Foster MDI and Relvar in patients with asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Foster MDI
  • RELVAR (fluticasone furoate/vilanterol)

Snippet

Sponsor: Far Eastern Memorial Hospital | Conditions: Asthma | Phase 4 | Status: UNKNOWN